Symbol
| GNAQ
| contributors: mct/pgu - updated : 23-01-2015
|
HGNC name
| guanine nucleotide binding protein (G protein), q polypeptide
|
HGNC id
| 4390
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| somatic mutation
|  
|  
|  
|
in uveal melanoma | tumoral
| somatic mutation
|  
|  
| gain of function
|
in iris melanomas | |
Susceptibility
|
to accelerated mortality in African-American heart failure to insulin resistance and obesity in PCOS (polycystic ovary syndrome) to uveal melanoma, and rapidly involuting congenital hemangioma [RICH] or non-involuting congenital hemangioma [NICH] |
Variant & Polymorphism
other
| -694/-695 promoter polymorphism alters transcription factor binding, increases promoter activity and adversely affects outcome in heart failure |
|
GNAQ promoter diplotypes are associated with insulin resistance and obesity in PCOS |
|
Glu209 GNAQ and GNA11 missense variants we identified are common in uveal melanoma, and in rapidly involuting congenital hemangioma [RICH] or non-involuting congenital hemangioma [NICH] |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
osteoarticular | bone | ostéoporosis | |
suppression of GNAQ signal may lead to a novel treatment in combination with PTH against osteoporosis | allergy | | | |
potential new target to prevent or treat anaphylactic reactions
|
| | | |